Skip to main content

Discovery of Natural Products from Microalgae and Marine Organisms

  • Chapter
  • 157 Accesses

Part of the book series: Developments in Oncology ((DION,volume 74))

Abstract

Screening of both synthetic organic compounds and extracts of natural products has had an impressive history of identifying active cytotoxic agents. Indeed, the majority of compounds, which have a significant role in clinical therapy at present were discovered either as a direct consequence of such screening or a subsequence of synthesis of analogs of lead drugs (Table 1). Specifically, the discovery of cytotoxic agents from natural sources has had a rich and fruitful past with the identification of agents such as vincristine and taxol from plants and a number of antibiotics such as adriamycin from fermentations.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sikic BI: Anticancer drug discovery. J. Nat. Cancer Inst. 83:738–740, 1991.

    Article  PubMed  CAS  Google Scholar 

  2. Devlin JP, Edwards OE, Gorham PR, et al: Anatoxina, a toxic alkaloid from Anabaena flos-aquae NRC-44h. Canad. J. Chem. 55:1367–1371, 1977.

    Article  CAS  Google Scholar 

  3. Mynderse JS, Moore RE, Kashiwagi M, Norton TR:Antileukemia activity in the Oscillatoriaceae: Isolation of debromoaplysiatoxin from Lyngbya. Science 196:538–540, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Cardellina JH, Marner FJ, Moore RE: Seaweed dermatitis: Structure of lyngbyatoxin A. Science 204: 193–195, 1979.

    Article  PubMed  CAS  Google Scholar 

  5. Moore RE, Patterson GML, Enteroth M, et al: Binding studies of [3H]lyngbyatoxin and [3H]debromoaplysiatoxin to the phorbol ester receptor in a mouse epidermal particulate fraction. Carcinogenesis 7:641–644, 1986.

    Article  PubMed  CAS  Google Scholar 

  6. Ishibashi M, Moore RE, Patterson GML, et al: Scytophycins, cytotoxic and antimycotic agents from the cyanophyte Scytonema pseudohofmanni. J. Org. Chem. 51:5300–5306, 1986.

    Article  CAS  Google Scholar 

  7. Moore RE, Patterson GML, Mynderse JS, et al: Toxins from cyanophytes belonging to the Scytonemataceae. Pure Appl. Chem. 58:263–271, 1986.

    Article  CAS  Google Scholar 

  8. Tachibana K, Echcucr PJ, Taukitani Y, et al: Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria. J. Amer. Chem. Soc. 103:2469–2471, 1981.

    Article  CAS  Google Scholar 

  9. Uemura D, Takahashi K, Yamamoto T, et al: Norhalichondrin A, an antitumor polyether macrolide from a marine sponge. J. Amer. Chem. Soc. 107:4796–4798, 1985.

    Article  CAS  Google Scholar 

  10. Chun HG, Davies B, Hoth D, et al: Didemnin B: The first marine compound entering clinical trials as an antineoplastic agent. Investigat. New Drugs 4:279–284, 1986.

    CAS  Google Scholar 

  11. Pettit GR, Herald CL, Doubek DL, Herald DL: Isolation and structure of bryostatin I. J. Amer. Chem. SOC. 104:6846–6848, 1982.

    Article  CAS  Google Scholar 

  12. Corbett T, Valeriote F, Baker L: Is the P388 murine tumor no longer adequate as a drug discovery model? Investigat. New Drugs 5:3–20, 1987.

    CAS  Google Scholar 

  13. Corbett TH, Valeriote FA, Polin L, et al: Discovery of solid tumor active agents using a soft-afar-colony-formation disk-diffusion-assay. FA Valeriote, TH Corbett, LH Baker (eds), Springer Science+Business Media New York, Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development, pp 35–87, 1992.

    Chapter  Google Scholar 

  14. Corbett TH, Valeriote FA: Rodent models in experimental chemotherapy. In: The Use of Rodent Tumors in Experimental Cancer Therapy: Conclusions and Recommendations. RF Kallman (ed), Pergamon Press, Chapter 50, pp 233–247, 1987.

    Google Scholar 

  15. Owen, SP, Smith, CG: Cytotoxicity and antitumor properties of the abnormal nucleoside tubercidin (NSC-56408). Cancer Chem. Rep., 36:19–22, 1964.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Valeriote, F., Moore, R.E., Patterson, G.M.L., Paul, V.J., Scheuer, P.J., Corbett, T. (1994). Discovery of Natural Products from Microalgae and Marine Organisms. In: Valeriote, F.A., Corbett, T.H., Baker, L.H. (eds) Anticancer Drug Discovery and Development: Natural Products and New Molecular Models. Developments in Oncology, vol 74. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2610-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2610-0_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6118-3

  • Online ISBN: 978-1-4615-2610-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics